Six Daiichi Sankyo Sales Reps File $100 Million Discrimination Suit In U.S.
This article was originally published in PharmAsia News
Executive Summary
A group of female Daiichi Sankyo sales representatives filed a $100 million class-action suit in the U.S., accusing the Japan drug maker of gender discrimination.